Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Projected Valuation Of The Epigenetics Market In The Coming Years?

The size of the epigenetics market has seen rapid expansion lately. Its expected growth trajectory will take it from $10.65 billion in 2024 to $12.74 billion in 2025, showcasing an impressive compound annual growth rate (CAGR) of 19.6%. This remarkable growth during the historical term is linked to several factors including a boost in research funding, a surge in chronic disease cases, the advent of personalized medicine, focus on cancer research, and an aging population.

Anticipated to experience swift growth in the coming years, the epigenetics market is projected to expand to $28.68 billion by 2029, with a compound annual growth rate (CAGR) of 22.5%. Various factors are contributing to this expansion in the prediction period, including development of epigenetic drugs, the role of epigenetics in environmental health and precision agriculture, supportive regulatory frameworks, and increasing patient awareness and advocacy. Upcoming trends in this period consist of epitranscriptomics, single-cell epigenomics, epigenetic editing, epigenetic biomarkers, research in aging and longevity, as well as interactions between microbiomes and epigenomes.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7070&type=smp

Which Growth Drivers Are Shaping The Epigenetics Market Outlook?

The escalation in the occurrence of cancer and other illnesses is notably fueling the expansion of the epigenetics market. The increasing incidence of these conditions boosts the need for epigenetics. For example, as stated by the National Cancer Institute (NCI), a government agency in the US, nearly 20 million novel cancer instances were identified in 2022, causing about 9.7 million fatalities attributable to the illness. Predictions suggest that by 2040, the yearly rate of new cancer diagnoses will rise to 29.9 million, with deaths due to cancer hitting 15.3 million. Moreover, based on data from the Centers for Disease Control and Prevention (CDC), around 659,000 individuals die from heart disease annually in the United States. The escalating occurrence of cancer and other ailments necessitates testing and recognizing the alterations in the genes, inevitably boosting the utilization and need for epigenetics. Hence, the surge in the incidence of cancer and other diseases propels the growth of the epigenetics market in the forthcoming years.

What Is The Segment Breakdown Of The Epigenetics Market?

The epigeneticsmarket covered in this report is segmented –

1) By Product: Reagents, Enzymes, Instruments, Kits

2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures

3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications

4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users

Subsegments:

1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes

2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases, Other Epigenetic Enzymes

3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers

4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion Kits

How Are Global Trends Impacting The Development Of The Epigenetics Market?

Leading businesses in the epigenetics market are concentrating their efforts on creating advanced technological solutions, such as DNA sequencing methods, that can drive precision medicine forward and yield better understanding and results in disease treatment. DNA sequencing methods are a set of techniques that ascertain the sequence of nucleotides in a DNA strand, facilitating in-depth genetic examination. This information is vital for highlighting genetic variations tied to diseases and for advancing the course of precision medicine. For example, Illumina Inc., a biotech corporation from the United States, inaugurated their Illumina Complete Long Read Technology in March 2023. This technology can perform both long-read and short-read sequencing on one piece of equipment, drastically increasing versatility in genomic research. By reducing the requirement for DNA input and streamlining the workflow, this technology simplifies the process of library preparation, thereby making it more user-friendly for challenging samples. It also excels in variant calling accuracy, providing dependable data that is critical for thorough genomic analysis.

Who Are The Major Stakeholders Operating In The Epigenetics Market?

Major companies operating in the epigenetics market include Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., Locus Biosciences Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/epigenetics-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Epigenetics Market?

North America was the largest region in the epigenetics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in the epigenetics market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=7070&type=smp

Browse Through More Reports Similar to the Global Epigenetics Market 2025, By The Business Research Company

Viral Vectors And Plasmid Dna Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Tumor Embolization Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/tumor-embolization-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model